Robert Hershberg, Director at Adaptive Biotechnologies Corp (ADPT), sold 3,439 shares at $39.13 ($135K) on 2020-08-17, disclosed to the SEC on 2020-08-19.
Open-market sale of $135k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.13 | 1,439 | $56K | 41.7% |
| 2 | $39.13 | 1,439 | $56K | 41.7% |
| 3 | $40.04 | 561 | $22K | 16.6% |
| Total | $39.28 avg | 3,439 | $135K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-12 | $367K | — | Filing → |
| ADPT | SELL | 2025-03-12 | $402K | — | Filing → |
| HLVX | SELL | 2025-02-12 | $49K | — | Filing → |